| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 103.80× | 103.80× | 105.78× | 100.20× | 67.94× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| −12.37× | −160.57× | −59.54× | 8.74× | 4.84× | ||
| 0.78× | 0.78× | 0.75× | 0.69× | 0.70× | ||
| 0.79× | 0.79× | 0.59× | −0.46× | 0.17× | ||
| 0.98× | 0.98× | 0.72× | −0.34× | 0.15× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 67.94 | 100.20 | 105.78 | 103.80 | 103.80 | |
| Working Capital Turnover | 4.84 | 8.74 | -59.54 | -160.57 | -12.37 | |
| Asset Turnover | 0.70 | 0.69 | 0.75 | 0.78 | 0.78 | |
| Cash Conversion (CFO/Net Income) | 0.17 | -0.46 | 0.59 | 0.79 | 0.79 | |
| CFO/EBITDA | 0.15 | -0.34 | 0.72 | 0.98 | 0.98 |